{"id":179955,"date":"2026-01-20T10:00:00","date_gmt":"2026-01-20T15:00:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/20\/abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science\/"},"modified":"2026-01-20T10:05:08","modified_gmt":"2026-01-20T15:05:08","slug":"abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/20\/abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science\/","title":{"rendered":"Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science"},"content":{"rendered":"<p><a href=\"https:\/\/www.prnewswire.com\/news-releases\/abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science-302665355.html\">Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science<\/a><\/p>\n<p><a href=\"https:\/\/www.prnewswire.com\/news-releases\/abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science-302665355.html\">https:\/\/www.prnewswire.com\/news-releases\/abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science-302665355.html<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-01-20 10:00:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.prnewswire.com\">www.prnewswire.com<\/a><\/p>\n<ul>\n<li>Abcam has joined the Innovative Health Initiative Project LIGAND-AI, a public-private partnership led by Structural Genomics Consortium and Pfizer, with a budget over \u20ac60 million.<\/li>\n<li>The objective of LIGAND-AI is to advance AI-driven drug discovery through open science by developing predictive models for next-generation therapeutics.<\/li>\n<li>Abcam will use its expertise in recombinant protein engineering to generate high-quality protein-ligand datasets essential for training the predictive models.<\/li>\n<li>The partnership involves experts from academia, industry, technology, and research organizations from nine countries, collaborating to create a large, open-access protein-ligand data resource.<\/li>\n<li>The project aims to create a seamless pipeline from experiments to AI predictions, reducing long timelines, substantial investments, and uncertainties in early drug discovery.<\/li>\n<li>LIGAND-AI will share all generated data following FAIR principles to ensure they are findable, accessible, interoperable, and reusable by the global scientific community.<\/li>\n<li>The initiative contributes to Target 2035, a broader mission aiming to discover chemical modulators for every human protein by 2035.<\/li>\n<li>The consortium also seeks to train a new generation of interdisciplinary scientists skilled in both computational methods and experimental protein science.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery&#8230;<\/p>\n","protected":false},"author":1,"featured_media":179956,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/mma.prnewswire.com\/media\/2865192\/Abcam_Logo.jpg?p=facebook","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[20],"class_list":["post-179955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/179955"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=179955"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/179955\/revisions"}],"predecessor-version":[{"id":179957,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/179955\/revisions\/179957"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/179956"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=179955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=179955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=179955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}